AppYea

AppYea Documents

Documents

100

Ticker

APYP

ISIN

US03834R2058

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

AppYea SEC Filings

Type
Report
Date
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/2/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/7/2026
10-QQuartalsbericht11/19/2025
NT 10-QNT 10-Q-Formular11/14/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/15/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/3/2025
PRE 14CPRE 14C-Formular9/12/2025
4Insidertransaktion9/5/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/5/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/21/2025
10-QQuartalsbericht8/18/2025
NT 10-QNT 10-Q-Formular8/14/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/14/2025
10-QQuartalsbericht5/15/2025
10-KJahresbericht4/15/2025
NT 10-KNT 10-K-Formular3/31/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/23/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/17/2025
10-QQuartalsbericht11/19/2024
NT 10-QNT 10-Q-Formular11/14/2024
10-QQuartalsbericht8/12/2024
10-QQuartalsbericht5/20/2024
10-K/A10-K/A-Formular5/17/2024
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/17/2024
NT 10-QNT 10-Q-Formular5/15/2024
10-KJahresbericht4/1/2024
424B3424B3-Formular2/26/2024
EFFECTEFFECT-Formular2/14/2024
POS AMPOS AM-Formular2/14/2024
POS AMPOS AM-Formular2/8/2024
10-QQuartalsbericht11/16/2023
NT 10-QNT 10-Q-Formular11/14/2023
S-8S-8-Formular11/13/2023
10-QQuartalsbericht8/14/2023
4/A4/A-Formular8/11/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/3/2023
4Insidertransaktion7/28/2023
33-Formular7/28/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/7/2023
10-QQuartalsbericht5/15/2023
10-KJahresbericht3/31/2023
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/10/2023
144144-Formular1/20/2023
144144-Formular12/20/2022
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/8/2022
424B3424B3-Formular11/21/2022
8-A12G8-A12G-Formular11/21/2022
10-QQuartalsbericht11/14/2022
EFFECTEFFECT-Formular9/29/2022
S-1/AS-1/A-Formular9/19/2022
S-1/AS-1/A-Formular8/29/2022
S-1/AS-1/A-Formular7/12/2022
DEL AMDEL AM-Formular5/11/2022
S-1S-1-Formular5/10/2022
15-12G15-12G-Formular6/29/2020
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/15/2020
10-QQuartalsbericht2/27/2020
NT 10-QNT 10-Q-Formular2/18/2020
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/13/2020
10-QQuartalsbericht11/19/2019
NT 10-QNT 10-Q-Formular11/14/2019
10-KJahresbericht10/18/2019
NT 10-KNT 10-K-Formular9/30/2019
PRE 14APRE 14A-Formular9/20/2019
4Insidertransaktion5/24/2019
10-QQuartalsbericht5/14/2019
10-QQuartalsbericht2/19/2019
NT 10-QNT 10-Q-Formular2/15/2019
10-QQuartalsbericht11/14/2018
10-KJahresbericht10/15/2018
NT 10-KNT 10-K-Formular10/1/2018
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/12/2018
10-QQuartalsbericht5/21/2018
NT 10-QNT 10-Q-Formular5/16/2018
10-QQuartalsbericht2/20/2018
NT 10-QNT 10-Q-Formular2/14/2018
DEF 14CDEF 14C-Formular1/19/2018
PRE 14CPRE 14C-Formular1/9/2018
10-QQuartalsbericht11/14/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/26/2017
10-KJahresbericht10/13/2017
NT 10-KNT 10-K-Formular9/29/2017
DEF 14CDEF 14C-Formular6/16/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/13/2017
PRE 14CPRE 14C-Formular6/6/2017
10-QQuartalsbericht5/19/2017
NT 10-QNT 10-Q-Formular5/15/2017
10-QQuartalsbericht2/14/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/13/2016
NT 10-QNT 10-Q-Formular11/14/2016
10-QQuartalsbericht11/14/2016
10-KJahresbericht9/30/2016
SC 13GSC 13G-Formular6/7/2016
10-QQuartalsbericht5/19/2016
NT 10-QNT 10-Q-Formular5/16/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/7/2016
10-Q/A10-Q/A-Formular3/3/2016
10-QQuartalsbericht3/2/2016
33-Formular2/18/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/18/2016

AppYea Documents 2026

This page contains all official documents and SEC filings for AppYea stock (APYP, ISIN: US03834R2058). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of AppYea's regulatory filings.

AppYea Stock analysis

AppYea AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps.